FDA Investigator Lawrence W Farina

Lawrence W Farina has conducted inspections on 75 sites in 1 countries as of 23 Feb 2005. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
75
Last Inspection Date:
23 Feb 2005
Investigator Role:
FDA Investigator
Redica ID:
100005397
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Lawrence W Farina:
Alice S Tsao, Althea A Williams, Amatul H Marium, Andrew M Abramowitz, Ann L Demarco, Ann M Stewart, Avital A Shimanovich, Aziz A Mamur, Benton M Ketron, Bijoy Panicker, Brandy N Lepage, Candace Y Gomez Broughton, Charanjeet Jassal, Charisse K Green, Ct Viswanathan, PhD, Daniel L Zheng, David R Delucia, Demitria J Xiradakis, Dennis E Guilfoyle, PhD, Dipesh K Shah, Donald G Gordon, Dongping Dai, PhD, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edouard Viard, Evan Tong, Felix Maldonado, Frank Verni, Gam S Zamil, Gary J Lehr, Gary T Greco, Gregson A Joseph, Guerlain Ulysse, Helen B Ricalde, Iram R Hassan, PhD, Jaison J Eapen, James A Liubicich, Jay T Wong, Jazmine N Brown, Jazmine N Still, John A Podsadowski, Jose Ohernandez Guzman, Joy P Matthias, Juan Rjimenez Garcia, Juanita P Versace, Justin A Boyd, Karishma G Gopaul, Kazi Rafiquzzaman, Kenneth H Williams, Kevin A Gonzalez, Kim Lthomas Cruse, Kwong P Lee, Linda M Sacco, Lisa M Smith, Margaret E Sarles, Marie B Buen Bigornia, Matthew A Spataro, Meredith P Soehl, Investigator, Michael A Charles, Michael Levin, Mindy M Chou, Nancy A Saxenian Emmons, Nariman Patenaude, Nazmul Hassan, Neil J Bonzagni, PhD MPH, Nerizza B Guerin, Nicholas C Mendiola, Nicole Vaught, Parul M Patel, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Paul Mouris, Perry T Nichols, Peter Abel, Peter Caparelli, Peter R Caparelli, Philip F Istafanos, DMV, MS, Rachael A Moliver, Raihan A Chowdhury, Rashmi Rawat, PhD, Richard Ferfoglia, Robert C Steyert, Rochelle K Kimmel, Ronald Ifraimov, Russ E Davis, Samina S Khan, Samuel T Walker, Sarah A Meehan, Sarah A Wangseng, Satheesh Thomas, Shari L Kahn, Simone E Pitts, Sony Mathews, Stephanie T Durso, Steven M Weinman, Susan M Joseph, Susan T Hadman, Suwaskie S Smith, Syeda N Mahazabin, Tanya R Syffrard, Terry Bridgewater, Thomas J Mooney, Thomas P Hansen, Tracy M Portelli, Uduak M Inokon, Valentino Fiorella, Vanessa M Williams, William M Rennells, Xiaoping Guan, Xikui Chen (nmi), PhD

Lawrence W Farina's Documents

Publish Date Document Type Title
July, 2000 FDA 483 Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer, Inc. - Form 483, 2000-07-21
December, 2002 EIR Chartwell Pharmaceuticals Amityville, LLC. - EIR, 2002-12-23
July, 2000 FDA 483 Response Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer, Inc. - Form 483R, 2000-07-25
May, 2001 FDA 483 P & L Development, LLC - Form 483, 2001-05-23
May, 2001 FDA 483 Response P & L Development, LLC - Form 483R, 2001-06-21
December, 2000 FDA 483 Bristol-Myers Squibb Co., Inc. - Form 483, 2000-12-15
September, 2003 FDA 483 Taro Pharmaceutical Laboratories, Inc. - Form 483, 2003-09-30
April, 2000 EIR Taro Pharmaceutical Laboratories, Inc. - EIR, 2000-04-05
June, 2000 EIR Inwood Labs - EIR, 2000-06-22
February, 2001 FDA 483 Response Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer, Inc. - Form 483R, 2001-02-21
May, 2001 EIR P & L Development, LLC - EIR, 2001-05-23
April, 2000 FDA 483 Response Taro Pharmaceutical Laboratories, Inc. - Form 483R, 2000-08-16
February, 2001 FDA 483 Wyeth-Ayerst Pharmaceuticals - Form 483, 2001-02-01
September, 2000 FDA 483 Inwood Labs - Form 483, 2000-09-28
October, 2002 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2002-10-28
June, 2000 FDA 483 Inwood Labs - Form 483, 2000-06-22
April, 2000 FDA 483 Taro Pharmaceutical Laboratories, Inc. - Form 483, 2000-04-05
October, 2002 EIR Fougera Pharmaceuticals Inc. - EIR, 2002-10-28
December, 2002 FDA 483 Chartwell Pharmaceuticals Amityville, LLC. - Form 483, 2002-12-23
September, 2000 EIR Inwood Labs - EIR, 2000-09-28
December, 2002 FDA 483 Response Chartwell Pharmaceuticals Amityville, LLC. - Form 483R, 2002-12-31
May, 1998 FDA 483 TIME CAP LABORATORIES, INC - Form 483, 1998-05-05
September, 2002 EIR Chartwell Pharmaceuticals Amityville, LLC. - EIR, 2002-09-19
August, 2003 FDA 483 Proper Chem Ltd - Form 483, 2003-08-27
September, 2002 FDA 483 Chartwell Pharmaceuticals Amityville, LLC. - Form 483, 2002-09-19
October, 2002 FDA 483 Response Fougera Pharmaceuticals Inc. - Form 483R, 2002-11-01
March, 2004 FDA 483 Z Cosmetica USA, LLC - Form 483, 2004-03-19

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more